What is the official ID of this bill?
The official print number for this legislation is HR 3932.
New Superbug Drugs: Support and Oversight Program
This act aims to accelerate the development of new drugs to combat resistant bacteria, which pose a serious health threat. It introduces a financial support system for pharmaceutical companies and mechanisms for monitoring and promoting the appropriate use of antibiotics to protect us from growing drug resistance.
Key points
Establishes a financial support program for companies developing new antibiotics, especially those targeting the most dangerous infections.
Creates an expert committee and an advisory group to identify key needs for new drugs and define their desired characteristics.
Introduces a "subscription contract" system where the government pays a fixed amount for access to new drugs, regardless of the number of doses sold, to encourage research investment.
Requires drug manufacturers to monitor drug resistance, ensure consistent supply, and promote appropriate antibiotic use.
Provides grants to hospitals for antibiotic stewardship programs and improved resistance data reporting.
Increases national surveillance of antibiotic use and resistance, making data publicly available.
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.